Stock Split History
How to Retire on 7%+ Dividends Paid Monthly »    QNRX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quoin Pharmaceuticals is a biotechnology company that has developed a platform known as ApoGraft that functionally selects stem cells in order to improve the regenerative medicine and stem cell therapies. Co. is conducting two clinical trials of ApoGraft, a Phase I/II clinical trial in Israel and a Phase I clinical study in Washington University. In addition, Co. is in the process of scaling up its product manufacturing capabilities based on its ApoGraft technology. ApoGraft is being tested for clinical use in allogeneic matched and half matched donors Hematopoietic Stem Cells Transplantation for the treatment of hematological malignancies (blood cancers such as leukemia and lymphoma). According to our Quoin Pharmaceuticals stock split history records, Quoin Pharmaceuticals has had 1 split.
Quoin Pharmaceuticals stock split history picture
Quoin Pharmaceuticals (QNRX) has 1 split in our Quoin Pharmaceuticals stock split history database. The split for QNRX took place on August 01, 2022. This was a 8 for 100 reverse split, meaning for each 100 shares of QNRX owned pre-split, the shareholder now owned 8 shares. For example, a 1000 share position pre-split, became a 80 share position following the split.

When a company such as Quoin Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Quoin Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 80 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Quoin Pharmaceuticals shares, starting with a $10,000 purchase of QNRX, presented on a split-history-adjusted basis factoring in the complete Quoin Pharmaceuticals stock split history. Quoin Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/02/2016
End date: 09/23/2022
Start price/share: $63.75
End price/share: $2.92
Dividends collected/share: $0.00
Total return: -95.42%
Average Annual Total Return: -39.45%
Starting investment: $10,000.00
Ending investment: $458.19
Years: 6.15
Date Ratio
08/01/20228 for 100
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Quoin Pharmaceuticals

Quoin Pharmaceuticals Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.